SuperworthMatinas BioPharma market cap MTNB
Share price times shares outstanding: what the whole company sells for, since 2014.
- Today, Oct 23, 2026
- $1.7M
- Highest close in our data
- $361.3M
- Jan 2020
Matinas BioPharma is worth $1.7M at the close on Oct 23, 2026, at $1.70 a share.
That is down 80% over the last year and down 99% over five years.
Its highest close in our data was $361.3M in Jan 2020.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $1.7M | $1.5M | $5.2M | −58% |
| 2025 | $4M | $2.7M | $12M | +51% |
| 2024 | $2.6M | $2.6M | $65.2M | −94% |
| 2023 | $47M | $28.2M | $132.7M | −57% |
| 2022 | $108.4M | $108.4M | $204.6M | −50% |
| 2021 | $218.4M | $143.9M | $326.8M | −19% |
| 2020 | $271M | $105.5M | $361.3M | −16% |
| 2019 | $322.2M | $67.3M | $322.2M | +370% |
| 2018 | $68.6M | $33.9M | $118M | −36% |
| 2017 | $107.8M | $81.8M | $274.2M | +33% |
| 2016 | $81.3M | $25.5M | $112.3M | +67% |
| 2015 | $48.6M | $11M | $80.8M | +236% |
| 2014 | $14.5M | $12.2M | $30.4M | n/a |
Against its peers
Companies in Healthcare nearest Matinas BioPharma's size, closest first, today.
| Company | Market cap |
|---|---|
| MTNBMatinas BioPharma | $1.7M |
| OXBROXBRIDGE RE HOLDINGS | $7.7M |
| EDUCEducational Development | $8.7M |
| GTIMGood Times Restaurants | $13.6M |
| MDRRMedalist Diversified | $15.4M |
| Peer median | $11.2M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Matinas BioPharma
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.